glucan synthase inhibitors (Roussel Uclaf)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameglucan synthase inhibitors (Roussel Uclaf)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis Pharma
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A